Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia.
about
The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options.Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.The functional role of reactive stroma in benign prostatic hyperplasia.Late-onset hypogonadism syndrome and lower urinary tract symptoms.Association of metabolic syndrome and benign prostate enlargement in young korean males.Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferationAssociation between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled studyThe difference of lower urinary tract symptoms between sympathetic hyperactive and hypoactive men.Lower urinary-tract symptoms and testosterone in elderly menThe Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.Doxazosin in metabolically complicated hypertension.The effect of Bongardia Chrysogonum on prostate tissue in a rat model of STZ-induced diabetes.Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey.Role of interleukins, IGF and stem cells in BPHStudying the effect of type 2 diabetes mellitus on prostate-related parameters: A prospective single institutional study.Review of exercise and the risk of benign prostatic hyperplasia.LUTS and sleep disorders: emerging risk factor.Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects.Metabolic Syndrome and Lower Urinary Tract Symptoms: Epidemiological Study.Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.Ginger Ingredients Alleviate Diabetic Prostatic Complications: Effect on Oxidative Stress and Fibrosis.The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS.Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome.Lower urinary tract symptoms in relation to lifestyle and medical conditions in Japanese workers.Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of holmium laser enucleation of the prostate.Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients.
P2860
Q30879509-550D5D9A-A1C9-4D1E-BBAE-F2D8A9B72B6EQ34114694-FFD7A932-61A9-4594-BAF4-2092ADFB24CEQ34442391-4E3462A8-507D-4B70-95D4-6697851935A0Q35070014-68A055FF-6E74-46DF-9103-78BA816E34E6Q35216293-ED341788-8D07-43A9-9C9C-93F0BDBC69A1Q35231687-7771CD49-B339-4ECE-B66B-0C1BD8B53047Q35539874-15D33B80-F455-4CFF-918A-30B1D1ED4C09Q35624518-CFABCCE4-5EC7-4E5A-8978-B6D13B868090Q36003050-D03541DB-70AF-416F-AE9D-4B1F6270A3B2Q36080363-57D44C47-3FB7-40EC-A74D-2FB9D35A51F9Q36170066-DC5DF230-0B59-45AA-B24D-A01EE069391FQ36770882-6EDF2465-82BD-4A70-B21B-4D73729BDAD8Q36839032-8D1453D4-C83C-45EB-B53B-0CE56BA0E0E1Q36993287-C8E4F7AC-210B-465A-8376-57BB977703A2Q37012904-608018AF-1687-43F8-A515-951ADB2A88DEQ37167114-E8F96747-D93C-44BB-944B-C4BA0E476FF5Q37406479-EA2EB29A-8411-4CD8-8FE5-ABD96B5AAF5FQ37416239-E2DA1B91-665E-4233-8E25-C7AA9A426CD9Q37496893-CA3B5033-21B2-47FC-A026-EA04CA5558DFQ37667615-1757B7C7-6ED6-47DB-97B0-D677D8FA21BCQ38053087-CE36E931-B75E-4370-8002-6B548F12CAC4Q38913900-46D4AA7F-90C1-4746-9211-AEED9E1699FAQ39095837-D72DD38A-07A6-4A3D-B3CE-B75D47AA2A28Q39275983-56B437C2-E269-451C-A195-D3D6A2619121Q40202608-293C0CA0-C623-465C-BCD1-6C815B5F7660Q40300137-E11AC761-E779-4BD1-BE3C-13837A7B9322Q41623248-F4601387-7031-47C6-8C21-AB9539D5713AQ43574338-6FA64793-7E8D-4776-827F-4162A3C46726Q43844386-50AC66AF-2857-48B3-8EFF-9DA6334E08C2Q46064053-B1A2EE35-07EB-406C-8200-3C130C2A69A2Q46526834-59C431D1-3FFF-404C-9B95-11581F24FEA5Q47192868-7A340B29-BF0E-429B-9557-2AFEC64A7030Q51386671-39CD9A62-8967-43A2-A48D-140C14770416
P2860
Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@ast
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@en
type
label
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@ast
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@en
prefLabel
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@ast
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@en
P2093
P1476
Metabolic syndrome and lower u ...... benign prostatic hyperplasia.
@en
P2093
Kevin T McVary
Sanjay Kasturi
Shane Russell
P2888
P304
P356
10.1007/S11934-996-0008-Y
P577
2006-07-01T00:00:00Z